TY  - JOUR 
AU  - Castellino, Giuseppa
AU  - Magán Fernández, Antonio
PY  - 2019
UR  - http://hdl.handle.net/10481/58543
AB  - The objective was to evaluate the effects of 6 months of supplementation with Altilix®,
containing chlorogenic acid and its derivatives, and luteolin and its derivatives, on cardiovascular
risk and hepatic markers in subjects with metabolic syndrome...
LA  - eng
PB  - MDPI
KW  - Cardiovascular diseases
KW  - Metabolic syndrome
KW  - Non-alcoholic fatty liver disease
KW  - Diabetes mellitus
KW  - Dietary supplements
KW  - Cynara
TI  - Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study
DO  - 10.3390/nu11112580
ER  -